ISPC vs BRLT

For growth investors, Brilliant Earth Group, Inc.

(BRLT) is the stronger pick with 3. 6% revenue growth year-over-year, versus -79. 2% for iSpecimen Inc. (ISPC). Analysts rate Brilliant Earth Group, Inc. (BRLT) a "Hold" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Brilliant Earth Group, Inc.

(BRLT) delivered a total return of -90. 3%, compared to -99. 9% for iSpecimen Inc. (ISPC). Over 10 years, the gap is even starker: BRLT returned -90. 2% versus ISPC's -99. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Brilliant Earth Group, Inc.

(BRLT) is the lower-risk stock at 1. 14β versus iSpecimen Inc. 's 1. 63β — meaning ISPC is approximately 42% more volatile than BRLT relative to the S&P 500. On balance sheet safety, iSpecimen Inc. (ISPC) carries a lower debt/equity ratio of 9% versus 48% for Brilliant Earth Group, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Brilliant Earth Group, Inc.

(BRLT) is pulling ahead at 3. 6% versus -79. 2% for iSpecimen Inc. (ISPC). On earnings-per-share growth, the picture is similar: iSpecimen Inc. grew EPS 87. 0% year-over-year, compared to -888. 6% for Brilliant Earth Group, Inc.. Over a 3-year CAGR, BRLT leads at -0. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Brilliant Earth Group, Inc.

(BRLT) is the more profitable company, earning -0. 8% net margin versus -543. 7% for iSpecimen Inc. — meaning it keeps -0. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BRLT leads at -1. 2% versus -465. 4% for ISPC. At the gross margin level — before operating expenses — BRLT leads at 57. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, BRLT (1.

8% yield) pays a dividend. ISPC does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Brilliant Earth Group, Inc.

(BRLT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 14), 1. 8% yield). iSpecimen Inc. (ISPC) carries a higher beta of 1. 63 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BRLT: -90. 2%, ISPC: -99. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ISPC (Healthcare) and BRLT (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

BRLT pays a dividend while ISPC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.